Valion Bio (VBIO) EBITDA Margin (QoQ) (2021 - 2025)
Valion Bio (VBIO) EBITDA Margin (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Valion Bio | 398,839.65 | -1.80 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 179,193.00 |
| Sep 30, 2025 | 54,815.00 |
| Jun 30, 2025 | -9,741.00 |
| Mar 31, 2025 | -132,754.00 |
| Dec 31, 2024 | 31,183.00 |
| Sep 30, 2024 | -23,143.00 |
| Jun 30, 2024 | -46,087.00 |
| Mar 31, 2024 | 18,516.00 |
| Dec 31, 2023 | -446.00 |
| Sep 30, 2023 | 69,576.00 |
| Jun 30, 2023 | -75,711.00 |
| Mar 31, 2023 | -982.00 |
| Dec 31, 2022 | -1,122.00 |
| Sep 30, 2022 | 2,987.00 |
| Jun 30, 2022 | -4,799.00 |
| Mar 31, 2022 | 6,560.00 |
| Dec 31, 2021 | -14,552.00 |
| Sep 30, 2021 | -5,003.00 |
| Jun 30, 2021 | -6,641.00 |